Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

17 February 2015

Versant, Frazier drive $30m Series B for US company Laguna Pharmaceuticals

BPL monitor Healthcare investors Versant Ventures and Frazier Healthcare have led a $30m financing round for cardia arrhythmia-focused Laguna Pharmaceuticals.

27 January 2015

China’s Legend Capital heads up $100m Series C for Innovent Biologics

pharmaceutical 12_sq Beijing-based venture capital firm Legend Capital has led a $100m Series C funding round for Chinese biopharmaceutical company Innovent Biologics.

7 January 2015

NeoMed co-leads $19.7m Series D for drug developer Genkyotex

pills-1111307-m European venture capital firm NeoMed Management has led a CHF20m ($19.7m) financing round for Genkyotex, a company developing drugs to treat diseases of the kidney, liver, lung and skin.

2 January 2015

NEA, KPCB back $28.5m 3-V Biosciences Series D

cancer juno Venture capital firms including New Enterprise Associates and Kleiner Perkins Caufield & Byers have backed a $28.5m Series D financing round for pharmaceutical business 3-V Biosciences.

5 December 2014

GSK abandons $3bn-plus plan to sell older drugs portfolio

pills-1111307-m Pharmaceutical giant GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe, despite strong interest from private equity firms and offers upwards of $3bn.

27 November 2014

Idinvest seals 7.6x return exiting Prosensa through $680m buyout

Prosensa Idinvest Partners has made a 7.6-times return by exiting its stake in Dutch biotechnology business Prosensa in a deal which values the business at $680m.

19 November 2014

Black Toro snaps up Spain’s Antibioticos

pills-755958-m Black Toro Capital has acquired Spanish pharmaceutical company Antibioticos.

7 November 2014

Waterland seals speedy exit of Belgian pharma business Omega in €3.6bn deal

green pills Omega Pharma , the Belgian pharmaceutical group backed by Dutch buy-out firm Waterland, has been bought by Ireland’s Perrigo in a €3.6bn deal.

6 November 2014

Drug development-focused NovaQuest back with $750m-targeting Fund IV

drug pharma bottle Pharmaceutical development-focused private equity firm NovaQuest Capital Management is believed to be back in the market with a $750m fourth fund.

5 November 2014

Bayer HealthCare earmarks $25m for Versant Ventures’ Fund V

medical-07-27065-m Healthcare and pharmaceutical conglomerate Bayer HealthCare is set to make a strategic investment of up to $25m to Versant Ventures’ fifth fund.

Page 1 of 1912345...10...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015